Your browser is no longer supported. Please, upgrade your browser.
Settings
NDRA ENDRA Life Sciences Inc. daily Stock Chart
NDRA [NASD]
ENDRA Life Sciences Inc.
Index- P/E- EPS (ttm)-2.01 Insider Own4.21% Shs Outstand5.48M Perf Week-11.78%
Market Cap21.76M Forward P/E- EPS next Y- Insider Trans- Shs Float5.07M Perf Month58.17%
Income-7.90M PEG- EPS next Q- Inst Own13.00% Short Float6.60% Perf Quarter71.86%
Sales0.30M P/S72.52 EPS this Y-155.80% Inst Trans16.33% Short Ratio0.93 Perf Half Y85.08%
Book/sh-0.12 P/B- EPS next Y- ROA- Target Price- Perf Year71.75%
Cash/sh0.11 P/C36.26 EPS next 5Y- ROE- 52W Range1.55 - 5.88 Perf YTD-18.32%
Dividend- P/FCF- EPS past 5Y- ROI-87.30% 52W High-32.48% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin59.50% 52W Low156.13% ATR0.63
Employees5 Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)47.12 Volatility11.69% 18.95%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.85 Prev Close4.12
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume361.55K Price3.97
Recom- SMA20-10.11% SMA5012.91% SMA20041.38% Volume306,174 Change-3.64%
Nov-13-18 03:01PM  ENDRA Life Sciences Announces Closing of Public Offering and Exercise of Over-Allotment Option ACCESSWIRE
Nov-08-18 07:31AM  ENDRA Life Sciences Prices Public Offering of Common Stock ACCESSWIRE
Nov-07-18 03:01PM  ENDRA Life Sciences Announces Proposed Public Offering of Common Stock ACCESSWIRE
Nov-05-18 03:01PM  ENDRA Life Sciences Reports Third Quarter 2018 Financial Results ACCESSWIRE
Oct-29-18 10:44AM  My Stock of the Week: ENDRA Life Sciences TheStreet.com
Oct-24-18 08:31AM  ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at Three Global Liver and Imaging Conferences in November 2018 ACCESSWIRE -13.20%
Oct-23-18 08:31AM  ENDRA Life Sciences to Host Third Quarter 2018 Results Conference Call on Monday, November 5, 2018 at 4:30 p.m. ET ACCESSWIRE
Oct-16-18 08:31AM  ENDRA Life Sciences Receives Approval to Initiate Human Studies of its TAEUS(TM) Device Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE +12.35%
Oct-15-18 04:01PM  ENDRA Life Sciences Announces Closing of Public Offering and Exercise of Over-Allotment Option ACCESSWIRE
Oct-11-18 08:50AM  ENDRA Life Sciences Inc. Prices Public Offering of Common Stock ACCESSWIRE -11.76%
07:39AM  The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's Gene-Edited Therapy, Endra To Offer Shares Benzinga
Oct-10-18 04:10PM  ENDRA Life Sciences Inc. Announces Proposed Public Offering of Common Stock ACCESSWIRE -9.57%
Aug-29-18 08:31AM  ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Geneva Switzerland on September 20-22, 2018 ACCESSWIRE
Aug-13-18 04:01PM  ENDRA Life Sciences Reports Second Quarter 2018 Financial Results ACCESSWIRE
Jul-31-18 08:31AM  ENDRA Life Sciences Granted Two U.S. Patents For Correcting Fat-Induced Aberrations & Imaging Biological Tissue Structures ACCESSWIRE
Jul-25-18 08:31AM  ENDRA Life Sciences to Host Second Quarter 2018 Results Conference Call on Monday, August 13, 2018 at 4:30 p.m. ET ACCESSWIRE -6.51%
Jul-12-18 08:31AM  ENDRA Life Sciences Granted U.S. Patent for Magnetic Resonance Imaging (MRI) Safety Based on TAEUS Technology ACCESSWIRE
Jul-02-18 08:31AM  ENDRA Life Sciences Completes Private Placement of $1.1 Million of Convertible Secured Notes and Warrants ACCESSWIRE
Jun-05-18 08:30AM  ENDRA Life Sciences Granted Third U.S. Patent for Non-Invasive Fat Assessment to Support TAEU(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE +11.67%
May-24-18 04:19PM  Should You Worry About ENDRA Life Sciences Incs (NASDAQ:NDRA) CEO Pay Check? Simply Wall St.
May-15-18 04:01PM  ENDRA Life Sciences Reports First Quarter 2018 Financial Results ACCESSWIRE -15.52%
Apr-26-18 08:31AM  ENDRA Life Sciences to Host First Quarter 2018 Results Conference Call on Tuesday, May 15, 2018 at 4:30 p.m. ET ACCESSWIRE
Apr-09-18 08:31AM  ENDRA Life Sciences to Showcase Photoacoustic Imaging Technology at American Association for Cancer Research (AACR) Annual Meeting on April 14-18 in Chicago ACCESSWIRE +10.38%
Apr-02-18 10:30AM  ENDRA Life Sciences to Present at The MicroCap Conference on Tuesday, April 10, 2018 ACCESSWIRE
Mar-20-18 04:01PM  ENDRA Life Sciences Reports Fourth Quarter and Full Year 2017 Financial Results ACCESSWIRE
Mar-08-18 12:59PM  ENDRA Life Sciences Inc (NASDAQ:NDRA): Does The -48.17% Earnings Decline Make It An Underperformer? Simply Wall St.
Mar-07-18 08:31AM  ENDRA Life Sciences to Host Fourth Quarter and Full Year 2017 Results Conference Call on Tuesday, March 20, 2018 at 4:30 p.m. ET ACCESSWIRE
Feb-27-18 08:31AM  ENDRA Life Sciences to Present at the Inaugural LD Micro Virtual Conference on Tuesday, March 6, 2018 at 5:00 p.m. ET ACCESSWIRE
Feb-15-18 08:31AM  ENDRA Life Sciences Granted Two U.S. Patents for Non-Invasive Fat Assessment to Support TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE +6.13%
Feb-05-18 08:31AM  ENDRA Life Sciences Renews and Extends Term of Collaboration Agreement with GE Healthcare to Develop ENDRA's TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE
Dec-27-17 05:25PM  Who Are The Top Investors In ENDRA Life Sciences Inc (NASDAQ:NDRA)? Simply Wall St.
Dec-08-17 06:33PM  What Did ENDRA Life Sciences Incs (NDRA) CEO Take Home Last Year? Simply Wall St. -7.94%
Nov-30-17 03:45PM  How ENDRA Life Sciences Incs (NDRA) EPS Dropped 45.2%, Did Its Industry Show Weakness Too? Simply Wall St.
Nov-22-17 08:31AM  ENDRA Life Sciences to Present at the 10th Annual LD Micro Main Event on December 6, 2017 ACCESSWIRE +11.72%
Nov-15-17 08:31AM  ENDRA Life Sciences Reports Third Quarter 2017 Financial Results ACCESSWIRE
08:17AM  Should Your Next Investment In The Healthcare Industry Be In ENDRA Life Sciences Inc (NDRA)? Simply Wall St.
Nov-08-17 09:22AM  ENDRA Life Sciences Contracts The Centre for Imaging Technology Commercialization (CIMTEC) to Initiate Human Studies with ENDRA's Clinical TAEUS(TM) Device Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE
Nov-02-17 08:31AM  ENDRA Life Sciences Partners with StarFish Medical and CriTech Research to Commence Development of TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE
Oct-23-17 08:31AM  ENDRA Life Sciences to Host Third Quarter 2017 Results Conference Call on Wednesday, November 15, 2017 at 4:30 p.m. ET ACCESSWIRE
Sep-28-17 08:31AM  ENDRA Life Sciences Completes Delivery and Installation of its Next Generation Nexus 128+ to Leading Research University in South Korea ACCESSWIRE
Sep-27-17 08:31AM  ENDRA Life Sciences to Participate at Upcoming Investor Conferences ACCESSWIRE
Sep-07-17 08:31AM  ENDRA Life Sciences to Participate at Upcoming Investor Conferences ACCESSWIRE -7.69%
Sep-06-17 08:31AM  ENDRA Life Sciences to Present New Photoacoustic Imaging Research at the 2017 World Molecular Imaging Congress on September 16, 2017 ACCESSWIRE
Aug-08-17 08:31AM  ENDRA Life Sciences Reports Second Quarter 2017 Financial Results ACCESSWIRE -11.14%
Jul-06-17 10:00AM  ENDRA Life Sciences Inc. (NASDAQ: NDRA) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound systems. It offers diagnostic imaging technologies, such as CT, MRI, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease or internal bleeding. It also offers the Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.